Eli Lilly (LLY.N) International President: The company will submit approval applications for the weight loss drug Orforglipron in the United States, the United Kingdom, the European Union, Japan and China within a few weeks.

2025-09-17

Eli Lilly (LLY.N) International President: The company will submit approval applications for the weight loss drug Orforglipron in the United States, the United Kingdom, the European Union, Japan and China within a few weeks.